Friederike Kröger

Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population

Christopher Blaum, Fabian J. Brunner, Friederike Kröger et al. · European Journal of Preventive Cardiology · 2019 · 55 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Target Populations and Treatment Cost for Bempedoic Acid and PCSK9 Inhibitors: A Simulation Study in a Contemporary CAD Cohort

Christopher Blaum, Fabian J. Brunner, Alina Goßling et al. · Clinical Therapeutics · 2021 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort

Christopher Blaum, Moritz Seiffert, Alina Goßling et al. · European Journal of Preventive Cardiology · 2020 · 19 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease

Fabian J. Brunner, Friederike Kröger, Christopher Blaum et al. · Atherosclerosis · 2020 · 12 citations

Medicine, Cardiology, Inflammation +11